Android Apple

Flagship, Quotient and Pfizer link on cardiovascular and renal disease

By Yahoo! Finance   |   3 months ago
Flagship, Quotient and Pfizer link on cardiovascular and renal disease

Flagship Pioneering and Quotient Therapeutics partner with Pfizer to discover new therapeutic targets for cardiovascular and renal diseases. They will analyze somatic mutations in diseased tissue to develop innovative treatments.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.